This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


GlaxoSmithKline plc

Drug Names(s): Casopitant mesylate, GW679769, Zunrisa

Description: Casopitant, an NK-1 antagonist, is an anti-emetic medicine. The neurokinin receptors (NK-1R, NK-2R, and NK-3R) are receptors for are a family of neuropeptides called tachykinins.

Rezonic News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug